Search Results

Site Search

Mayo Clinic Laboratory and Pathology Research Roundup: April 2 - Insights

This week's research roundup feature: Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma of germinal center origin, which presents with significant biologic and clinical heterogeneity. Using RNA-seq on B cells sorted from 87 FL...

Optimizing Cancer Care: ASCO Guidelines for Germline Genetic Testing - Insights

PACE / State of FL- Presentation Recording Coming Soon This webinar will delve into the latest ASCO guidelines for selection of germline genetic testing panels for cancer patients. Key topics include the importance of taking and recording a...

Metagenomic Sequencing - A Tool for Diagnosis of Central Nervous System Infection - Insights

PACE / State of FL This webinar will cover metagenomic sequencing for diagnosing central nervous system infection. Content will be shared regarding technical details, clinical applications, and results interpretation, drawing on both...

Sickle cell disease: How new technologies are transforming patient lives - Insights

In this “Future Direction of Laboratory Medicine” webinar, Maggie DiGuardo, M.D., and Justin Juskewitch, M.D., Ph.D., will review the current knowledge regarding sickle cell disease from its genetic cause to the myriads of effects it can...

Understanding a Broken Heart: Genetic Testing After Sudden Cardiac Death - Insights

PACE/State of FLPresentation Recording Coming Soon Sudden cardiac death (SCD) is a devastating event that occurs unexpectedly, often without any prior symptoms. This webinar will discuss how postmortem genetic testing may be used in...

IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights

In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.

Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. - Insights

Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.

MCL @Work: Brian Dukek - Insights

As a senior principal developer for the brand-new Process Innovation Through Automation Laboratory, Brian Dukek helps labs throughout the Department of Laboratory Medicine and Pathology evaluate new automation tools and streamline...

Early-Onset IBD: Genetic Testing and Clinical Applications - Insights

Identification of early-onset IBD patients may enable tailored treatment and surveillance plans. With over 50 genes implicated in early-onset IBD, genetic testing should be included in the workup of children under the age of six with IBD....

Testing Options for Patients with Chronic Diarrhea: A Focus on Bile Acid Malabsorption - Insights

This "Specialty Testing" webinar describes a new serum test for bile acid malabsorption. Descriptions illustrate how the test can be used as a screening test and as a tool for therapeutic action.